Noxopharm and UniSA receive Tour de Cure grant for brain cancer research
Noxopharm Ltd (ASX:NOX, OTC:NOXOF) and the University of South Australia (UniSA) have received A$100,000 from Tour de Cure to progress their encouraging...
Source: proactiveinvestors.com